STAT1 and neoplasm: Considering the abovementioned experimental results, CPPS-II is likely to drive repolarization of M2 TAMs to M1 TAMs by promoting Stat1 phosphorylation and inhibiting Stat3 activation to modify tumor-associated macrophages in order to achieve tumor treatment effect through immunotherapy.